625 related articles for article (PubMed ID: 26352814)
1. Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.
Kelly RJ; Höchsmann B; Szer J; Kulasekararaj A; de Guibert S; Röth A; Weitz IC; Armstrong E; Risitano AM; Patriquin CJ; Terriou L; Muus P; Hill A; Turner MP; Schrezenmeier H; Peffault de Latour R
N Engl J Med; 2015 Sep; 373(11):1032-9. PubMed ID: 26352814
[TBL] [Abstract][Full Text] [Related]
2. [Management of pregnancy and delivery in patients with paroxysmal nocturnal hemoglobinuria].
Usuki K
Rinsho Ketsueki; 2015 Jul; 56(7):785-94. PubMed ID: 26251141
[TBL] [Abstract][Full Text] [Related]
3. Management of pregnancy in paroxysmal nocturnal hemoglobinuria on long-term eculizumab.
Vekemans MC; Lambert C; Ferrant A; Saussoy P; Havelange V; Debiève F; Van Den Neste E; Michaux L
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):464-6. PubMed ID: 25688464
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.
Miyasaka N; Miura O; Kawaguchi T; Arima N; Morishita E; Usuki K; Morita Y; Nishiwaki K; Ninomiya H; Gotoh A; Imashuku S; Urabe A; Shichishima T; Nishimura J; Kanakura Y
Int J Hematol; 2016 Jun; 103(6):703-12. PubMed ID: 26857155
[TBL] [Abstract][Full Text] [Related]
5. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab.
Kelly R; Arnold L; Richards S; Hill A; Bomken C; Hanley J; Loughney A; Beauchamp J; Khursigara G; Rother RP; Chalmers E; Fyfe A; Fitzsimons E; Nakamura R; Gaya A; Risitano AM; Schubert J; Norfolk D; Simpson N; Hillmen P
Br J Haematol; 2010 May; 149(3):446-50. PubMed ID: 20151973
[TBL] [Abstract][Full Text] [Related]
6. Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria.
Keating GM; Lyseng-Williamson KA; McKeage K
BioDrugs; 2012 Apr; 26(2):125-30. PubMed ID: 22350448
[TBL] [Abstract][Full Text] [Related]
7. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
Hillmen P; Young NS; Schubert J; Brodsky RA; Socié G; Muus P; Röth A; Szer J; Elebute MO; Nakamura R; Browne P; Risitano AM; Hill A; Schrezenmeier H; Fu CL; Maciejewski J; Rollins SA; Mojcik CF; Rother RP; Luzzatto L
N Engl J Med; 2006 Sep; 355(12):1233-43. PubMed ID: 16990386
[TBL] [Abstract][Full Text] [Related]
8. Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn.
Hallstensen RF; Bergseth G; Foss S; Jæger S; Gedde-Dahl T; Holt J; Christiansen D; Lau C; Brekke OL; Armstrong E; Stefanovic V; Andersen JT; Sandlie I; Mollnes TE
Immunobiology; 2015 Apr; 220(4):452-9. PubMed ID: 25468724
[TBL] [Abstract][Full Text] [Related]
9. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
[TBL] [Abstract][Full Text] [Related]
10. Eculizumab treatment in pregnant women with paroxysmal nocturnal hemoglobinuria: A Polish experience.
Czyż J; Szukalski Ł; Szukalska A; Budziszewska BK; Lech-Marańda E; Zdziarska J; Sacha T
Adv Clin Exp Med; 2022 Jun; 31(6):707-710. PubMed ID: 35699586
[TBL] [Abstract][Full Text] [Related]
11. Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria.
McKeage K
Drugs; 2011 Dec; 71(17):2327-45. PubMed ID: 22085388
[TBL] [Abstract][Full Text] [Related]
12. Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.
Risitano AM; Marotta S; Ricci P; Marano L; Frieri C; Cacace F; Sica M; Kulasekararaj A; Calado RT; Scheinberg P; Notaro R; Peffault de Latour R
Front Immunol; 2019; 10():1157. PubMed ID: 31258525
[TBL] [Abstract][Full Text] [Related]
13. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.
Hillmen P; Szer J; Weitz I; Röth A; Höchsmann B; Panse J; Usuki K; Griffin M; Kiladjian JJ; de Castro C; Nishimori H; Tan L; Hamdani M; Deschatelets P; Francois C; Grossi F; Ajayi T; Risitano A; Peffault de Latour R
N Engl J Med; 2021 Mar; 384(11):1028-1037. PubMed ID: 33730455
[TBL] [Abstract][Full Text] [Related]
14. [Pregnancy and delivery in a PNH patient treated with eculizumab].
Ando Y; Kida M; Saika M; Chizuka A; Hangaishi A; Urabe A; Usuki K
Rinsho Ketsueki; 2014 Nov; 55(11):2288-93. PubMed ID: 25501409
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria.
Reiss UM; Schwartz J; Sakamoto KM; Puthenveetil G; Ogawa M; Bedrosian CL; Ware RE
Pediatr Blood Cancer; 2014 Sep; 61(9):1544-50. PubMed ID: 24777716
[TBL] [Abstract][Full Text] [Related]
16. Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Loschi M; Porcher R; Barraco F; Terriou L; Mohty M; de Guibert S; Mahe B; Lemal R; Dumas PY; Etienne G; Jardin F; Royer B; Bordessoule D; Rohrlich PS; Fornecker LM; Salanoubat C; Maury S; Cahn JY; Vincent L; Sene T; Rigaudeau S; Nguyen S; Lepretre AC; Mary JY; Corront B; Socie G; Peffault de Latour R
Am J Hematol; 2016 Jun; 91(4):366-70. PubMed ID: 26689746
[TBL] [Abstract][Full Text] [Related]
17. Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
Danilov AV; Brodsky RA; Craigo S; Smith H; Miller KB
Leuk Res; 2010 May; 34(5):566-71. PubMed ID: 19954846
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.
Hillmen P; Elebute M; Kelly R; Urbano-Ispizua A; Hill A; Rother RP; Khursigara G; Fu CL; Omine M; Browne P; Rosse W
Am J Hematol; 2010 Aug; 85(8):553-9. PubMed ID: 20658586
[TBL] [Abstract][Full Text] [Related]
19. Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience.
de Guibert S; Peffault de Latour R; Varoqueaux N; Labussière H; Rio B; Jaulmes D; Eveillard JR; Dulucq S; Stoppa AM; Bouscary D; Girodon F; Bonnotte B; Laskri D; Socié G; Lamy T
Haematologica; 2011 Sep; 96(9):1276-83. PubMed ID: 21606169
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial.
Kanakura Y; Ohyashiki K; Shichishima T; Okamoto S; Ando K; Ninomiya H; Kawaguchi T; Nakao S; Nakakuma H; Nishimura J; Kinoshita T; Bedrosian CL; Valentine ME; Khursigara G; Ozawa K; Omine M
Int J Hematol; 2011 Jan; 93(1):36-46. PubMed ID: 21222185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
